1. Baseline type 2 biomarker levels and response to tezepelumab in severe asthma. Issue 6 (9th February 2022) Authors: Corren, Jonathan; Pham, Tuyet‐Hang; Garcia Gil, Esther; Sałapa, Kinga; Ren, Pin; Parnes, Jane R.; Colice, Gene; Griffiths, Janet M. Journal: Allergy Issue: Volume 77:Issue 6(2022) Page Start: 1786 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Increased mast cell activation in eosinophilic chronic obstructive pulmonary disease. Issue 9 (26th September 2022) Authors: Higham, Andrew; Dungwa, Josiah; Pham, Tuyet‐Hang; McCrae, Christopher; Singh, Dave Journal: Clinical & translational immunology Issue: Volume 11:Issue 9(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. The relationship between airway immunoglobulin activity and eosinophils in COPD. Issue 4 (27th December 2020) Authors: Southworth, Thomas; Higham, Andrew; Kolsum, Umme; Li, Jian; Scott, Thomas; Dungwa, Josiah; Sridhar, Sriram; Pham, Tuyet‐Hang; Newbold, Paul; Singh, Dave Journal: Journal of cellular and molecular medicine Issue: Volume 25:Issue 4(2021) Page Start: 2203 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Type 2 inflammation in eosinophilic chronic obstructive pulmonary disease. Issue 6 (5th December 2020) Authors: Higham, Andrew; Beech, Augusta; Wolosianka, Sophie; Jackson, Natalie; Long, Gabriella; Kolsum, Umme; Southworth, Thomas; Pham, Tuyet‐Hang; Sridhar, Sriram; McCrae, Christopher; Newbold, Paul; Singh, Dave Journal: Allergy Issue: Volume 76:Issue 6(2021) Page Start: 1861 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗